Loading...
Indian Pharmaceutical Exporter · #7 for Ampicillin · $4.1M export value · DGFT Verified
Medreich Limited is the #7 Indian exporter of Ampicillin with $4.1M in export value and 102 verified shipments. Medreich Limited holds a 2.9% market share in Ampicillin exports across 5 countries. The company exports 42 pharmaceutical products worth $224.8M across 15 therapeutic categories.
| 1 |
| 1.9% |
| PORTUGAL | $49.1K | 7 | 1.9% |
Medreich Limited exports Ampicillin to 6 countries. The largest destination is NIGERIA accounting for 73.7% of Medreich Limited's Ampicillin shipments, followed by KENYA (12.9%) and HONG KONG (5.4%). These destinations reflect Medreich Limited's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| WORLDWIDE COMMERICAL VENTURES LTD | NIGERIA | $1.3M | 48 |
| WORLDWIDE COMMERICAL VENTURES LIMITED | NIGERIA | $277.1K | 8 |
| SANOFI AVENTIS NIGERIA LTD | NIGERIA | $186.2K | 5 |
| GSK PHARMACEUTICAL KENYA LTD | KENYA | $177.0K | 9 |
| SURGIPHARM LTD | KENYA | $125.4K | 6 |
| AL-JABER PHARMA FOR DRUGS&MEDICAL | YEMEN, DEMOCRATIC | $110.4K | 4 |
| PHARMASON COMPANY LIMITED | HONG KONG | $89.1K | 3 |
| AGUAWKA VENTURES LTD | NIGERIA | $78.2K | 4 |
| AGUAWKA VENTURES LIMITED | NIGERIA | $59.3K | 2 |
| DKSH HONG KONG LIMITED | HONG KONG | $53.6K | 2 |
Medreich Limited supplies Ampicillin to 16 buyers globally. The largest buyer is WORLDWIDE COMMERICAL VENTURES LTD (NIGERIA), followed by WORLDWIDE COMMERICAL VENTURES LIMITED (NIGERIA) and SANOFI AVENTIS NIGERIA LTD (NIGERIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
India exported $52.7M worth of Ampicillin through 4,470 shipments from 486 suppliers to 133 countries, serving 924 buyers globally. Medreich Limited contributes $4.1M to this total, accounting for 2.9% of India's Ampicillin exports. Medreich Limited ships Ampicillin to 6 countries through 16 buyers.
Medreich Limited's average Ampicillin shipment value is $40.6K per consignment, based on 102 shipments totaling $4.1M. The largest destination is NIGERIA (73.7% of Medreich Limited's Ampicillin exports).
Medreich Limited ranks #7 among 486 Indian Ampicillin exporters with a 2.9% market share. The top 3 exporters are STERISCIENCE SPECIALTIES PRIVATE LIMITED ($12.9M), SPARSH BIO-TECH PRIVATE LIMITED ($10.4M), AUROBINDO PHARMA LTD ($4.7M). Medreich Limited processed 102 shipments to 5 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| AMPICILLIN 250MG+CLOXACILLIN 250MG CAPSU | $169.2K | 4 |
| AMPICILLIN AND CLOXACILLIN CAPSULES 500MG (AMPICLOX- 500 MG) 10X10S (47150 PACKS) | $150.0K | 3 |
| AMPICILLIN AND CLOXACILLIN NEONATAL DROP | $146.1K | 8 |
| AMPICILLIN & CLOXACILLIN NEONATAL DROPS | $113.7K | 6 |
| AMPICILLIN AND CLOXACILLIN CAPSULES 500MG (AMPICLOX- 500 MG) 10X10S (11800 PACKS) | $97.9K | 6 |
| AMPICILLIN 250MG AND CLOXACILLIN 250MG C | $87.3K | 4 |
| AMPICILLIN AND CLOXACILLIN CAPSULES 500MG (AMPICLOX-500 MG) 10X10S (17700 PACKS) | $73.5K | 3 |
| AMPICILLIN WITH CLOXACILLIN CAPSULES 500 | $53.2K | 2 |
| AMPICILLIN WITH CLOXACILLIN CAPSULES 500MG REICHLOX 10X10S 20543 PACKS | $50.0K | 1 |
| AMPICILLIN WITH CLOXACILLIN CAPSULES 500MG (REICHLOX) 10X10S (27142 PACKS) | $50.0K | 1 |
Medreich Limited exports 59 distinct Ampicillin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is AMPICILLIN 250MG+CLOXACILLIN 250MG CAPSU with 4 shipments worth $169.2K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
What Medreich Limited must comply with to export Ampicillin to its top destination countries
Approval Process
Drug registration under NAFDAC guidelines. WHO-type CPP from India required.
Timeline: 6–18 months
GMP & Export Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Certificate of Pharmaceutical Product (CPP) from CDSCO India; NAFDAC import permit
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified Indian site inspections.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | SPARSH BIO-TECH PRIVATE LIMITED | $10.4M | 209 | 3 | $50.0K |
| 6 | AUROBINDO PHARMA LTD | $4.7M | 106 | 10 | $44.1K |
| 7 | MEDREICH LIMITED ★ | $4.1M | 102 | 5 | $40.6K |
| 4 | AMN LIFE SCIENCE PRIVATE LIMITED | $4.0M | 81 | 2 | $50.0K |
| 8 | KARNATAKA ANTIBIOTICS AND PHARMACEUTICALS LIMITED | $3.1M | 103 | 9 | $30.0K |
Medreich Limited ranks #7 among 486 Indian Ampicillin exporters. Average shipment value of $40.6K compared to the market average of $108.4K. The closest competitors by value are SPARSH BIO-TECH PRIVATE LIMITED and AUROBINDO PHARMA LTD.
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 412 | 9.2% |
| DELHI AIR CARGO ACC (INDEL4) | 317 | 7.1% |
| SAHAR AIR CARGO ACC (INBOM4) | 301 | 6.7% |
| SAHAR AIR | 259 | 5.8% |
| DELHI AIR | 233 | 5.2% |
| BANGALORE ICD | 226 | 5.1% |
| MUNDRA SEA | 205 | 4.6% |
| JNPT/ NHAVA SHEVA SEA | 204 | 4.6% |
Medreich Limited also exports these antibiotics products. Each links to the detailed product page.
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Medreich Limited. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased shipping costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structures of exporters relying on these routes. (sgeexport.com)
Conversely, the US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, the imposition of tariffs on pharmaceutical imports by the US poses a risk to Indian companies, as higher tariffs could render low-margin generic drugs unprofitable, leading to market exits and exacerbating drug shortages in the US. (cfo.economictimes.indiatimes.com)
The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a favorable development for Medreich. The FTA eliminates tariffs on Indian pharmaceutical products entering the EU, providing immediate cost relief and enhancing market access. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, creating new opportunities for companies like Medreich to expand their presence in the EU market. (en.wikipedia.org)
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The US Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practices (EU GMP) set stringent quality requirements that companies must adhere to for market access. Recent regulatory frameworks have increased compliance costs by an average of 18.7%, leading to a 15.2% reduction in export volumes to the US in the first quarter of 2025. (transdatanexus.com)
For Medreich Limited, maintaining compliance with these evolving standards is crucial to sustaining and expanding its export markets. Investments in quality assurance, regular audits, and staying abreast of regulatory changes are essential strategies to navigate this complex landscape.
Medreich Limited exports 42 products worth $224.8M. Beyond Ampicillin, top products include Amoxicillin, Potassium, Flucloxacillin, Rosuvastatin, Atorvastatin. View the complete Medreich Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Ampicillin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 133+ countries, 924+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Medreich Limited's Ampicillin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Medreich Limited
Full Company Profile →
42 products · $224.8M total trade · 15 categories
Access shipment-level records, pricing trends, and buyer contacts for Medreich Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ampicillin. For current shipment-level data, contact TransData Nexus.